LabGenomics Co. Ltd (084650) — Capital Reinvestment Ratio
LabGenomics Co. Ltd (084650) has a Capital Reinvestment Ratio of 0.18x as of December 2023, meaning it reinvests 0% of its operating cash flow (₩4.96 Billion) in capital expenditures (₩895.50 Million). See 084650 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
LabGenomics Co. Ltd Capital Reinvestment Ratio (2014–2023)
This chart tracks LabGenomics Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. Check 084650 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for LabGenomics Co. Ltd (2014–2023)
Year-by-year Capital Reinvestment Ratio for LabGenomics Co. Ltd from 2014 to 2023. For live market cap and broader valuation context, see LabGenomics Co. Ltd (084650) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.15x | ₩2.42 Billion | ₩5.20 Billion | ▲ +291.1% |
| 2022 | 0.55x | ₩69.87 Billion | ₩38.33 Billion | ▲ +161.4% |
| 2021 | 0.21x | ₩65.36 Billion | ₩13.72 Billion | ▲ +1291.8% |
| 2020 | 0.02x | ₩46.37 Billion | ₩699.21 Million | ▼ -91.4% |
| 2019 | 0.18x | ₩3.19 Billion | ₩560.94 Million | ▼ -94.7% |
| 2018 | 3.33x | ₩608.03 Million | ₩2.03 Billion | ▲ +108.0% |
| 2016 | 1.60x | ₩2.54 Billion | ₩4.08 Billion | ▼ -17.6% |
| 2015 | 1.95x | ₩2.38 Billion | ₩4.63 Billion | ▲ +409.3% |
| 2014 | 0.38x | ₩3.15 Billion | ₩1.20 Billion | — |